Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122579) titled 'Single-Center, Randomized, Double-Blind Trial of Anrikefon versus Tramadol for Postoperative Nausea and Vomiting following Laparoscopic Bariatric Surgery' on April 15.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Beijing Friendship Hospital ,Capital Medical University
Condition:
Postoperative nausea and vomiting (PONV)
Intervention:
Trial Group:Anruikefen injection, single dose of 1µg/kg, administered once every 8 hours for a total of 7 doses within 48 hours
first dose given within 3 hours postoperatively, diluted to 50ml and infused over 30 minutes
Control Group:Tramadol ...